[Changes in the acetylcholine-cholinesterase and ATP-ATPase systems in the stomach wall during experimental dystrophy and its treatment by ganglionic blockers].
R A
RA
Nazaretian
D000109:Acetylcholine / Q000378:metabolism*; D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D002802:Cholinesterases / Q000378:metabolism*; D005730:Ganglionic Blockers / Q000627:therapeutic use*; D005753:Gastric Mucosa / Q000378:metabolism*; D008297:Male; D009130:Muscle, Smooth / Q000201:enzymology / Q000378:metabolism*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D051381:Rats; D013270:Stomach / Q000187:drug effects / Q000201:enzymology; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000378:metabolism*
D005730:Ganglionic Blockers; D000644:Quaternary Ammonium Compounds; C008342:quateron; D000255:Adenosine Triphosphate; D002802:Cholinesterases; D000251:Adenosine Triphosphatases; D000109:Acetylcholine